Equities
Health CareMedical Equipment and Services
  • Price (SEK)196.50
  • Today's Change-2.50 / -1.26%
  • Shares traded359.97k
  • 1 Year change-44.38%
  • Beta0.9424
Data delayed at least 15 minutes, as of Oct 05 2022 12:11 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

  • Revenue in SEK (TTM)27.15bn
  • Net income in SEK2.67bn
  • Incorporated1990
  • Employees10.99k
  • Location
    Getinge ABLindholmspiren 7,P.O. Box 8861GOETEBORG 417 56SwedenSWE
  • Phone+46 35155500
  • Fax+46 8295532
  • Websitehttps://www.getinge.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Arjo AB (publ)9.48bn647.00m10.54bn6.59k17.461.536.401.112.382.3834.7927.110.62243.506.391,445,987.004.243.056.964.4644.8244.936.824.850.721311.730.484345.10-0.08813.0441.068.65----
Biotage AB1.43bn227.00m10.54bn499.0046.427.1233.587.383.443.4421.6622.440.80052.296.282,873,240.0012.7314.8715.4817.8061.3461.3715.9017.181.6515.960.115844.4712.7913.0316.9217.183.334.40
Revenio Group Oyj950.61m220.07m11.26bn188.0051.3213.0543.0811.850.75960.75963.282.990.76567.378.82477,054.3017.6416.3120.6919.9850.0551.8823.0422.281.61--0.226969.8429.0027.4429.6324.259.80-14.40
Ossur hf8.10bn643.88m18.33bn3.67k28.612.6314.632.261.041.0413.1711.320.57922.546.681,516,513.004.735.595.706.5062.3263.038.178.700.79411.550.411610.0714.166.65929.844.631.66--
Elekta AB (publ)14.87bn1.09bn20.56bn4.72k19.592.359.731.382.852.8538.9023.760.58843.382.993,128,815.004.314.847.828.8637.7341.037.338.880.817811.880.385655.055.706.33-7.9755.9812.7119.14
Ambu A/S6.27bn323.27m21.00bn4.91k73.673.8329.553.350.87610.876116.9916.850.68981.986.38939,572.403.567.124.429.0458.5160.095.159.390.9248--0.265730.1512.5014.002.49-0.241232.50-1.32
GN Store Nord A/S24.18bn1.32bn31.13bn8.11k22.213.009.241.297.017.01129.1951.960.71023.254.812,297,039.004.079.045.8912.2052.8058.315.7311.120.55829.040.700533.6317.2912.7740.2610.0914.206.15
Getinge AB27.15bn2.67bn46.94bn10.99k18.871.8110.471.739.799.7999.67102.140.60232.586.562,530,152.005.983.347.264.4548.9048.069.925.781.4028.170.160140.67-9.294.06-8.3133.59-10.3615.20
Demant A/S27.17bn3.85bn65.92bn18.13k17.105.77--2.4311.4910.3781.1234.060.73282.055.311,106,131.0010.429.0718.4914.7875.1675.2314.2211.960.587945.490.62120.0023.758.33140.5013.0711.99--
Coloplast A/S31.48bn6.96bn219.13bn14.00k33.8722.1826.676.9622.4422.44101.4834.270.85382.506.201,698,617.0018.8832.3527.4054.6168.8367.9522.1123.370.657996.370.73987.954.765.7614.968.9524.827.07
Data as of Oct 05 2022. Currency figures normalised to Getinge AB's reporting currency: Swedish Krona SEK

Institutional shareholders

33.79%Per cent of shares held by top holders
HolderShares% Held
Fj�rde AP-fondenas of 31 Jan 202220.28m7.98%
AMF Fonder ABas of 21 Jun 202213.81m5.43%
Swedbank Robur Fonder ABas of 31 Jan 20229.79m3.85%
Handelsbanken Fonder ABas of 31 Aug 20229.57m3.76%
Schroder Investment Management Ltd.as of 31 Jan 20226.82m2.69%
Norges Bank Investment Managementas of 31 Jan 20226.51m2.56%
The Vanguard Group, Inc.as of 09 Sep 20225.85m2.30%
Didner & Gerge Fonder ABas of 31 Dec 20215.35m2.10%
The Caisse de d�p�t et placement du Qu�becas of 31 Jan 20224.18m1.65%
Carnegie Fonder ABas of 31 Aug 20223.71m1.46%
More ▼
Data from 31 Dec 2021 - 31 Aug 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.